Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Androtab-SL NDA is inadequate for approval, FDA says

Feb. 3, 1998

EPO peptides and anti-EPO antibodies from Behringwerke

Feb. 3, 1998

Somatostatin receptor ligands synthesized by Novo Nordisk

Feb. 2, 1998

Schering-Plough to copromote Novo Nordisk's Prandin

Jan. 30, 1998

Oxytocin antagonist licensed by Tokyo Tanabe enters clinic

Jan. 30, 1998

Roche patents vitamin D analogues for osteoporosis

Jan. 30, 1998

Comparative trial of intracavernous alprostadil and MUSE for ED

Jan. 29, 1998

BioMarin's lead enzyme replacement therapy enters clinical trials

Jan. 28, 1998

Common variant of CETP gene correlated with atherosclerosis progression, response to pravastatin

Jan. 27, 1998

Wyeth-Ayerst licenses PEPCK-modulating compounds

Jan. 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...